Banner

MATERNAL SERUM FERRITIN LEVEL AT 30-32 WEEKS GESTATION AS A BIOMARKER FOR PREDICTION OF ASYMMETRICAL INTRAUTERINE GROWTH RESTRICTION

• 2015
Back
Publication Information
Authors Ayman Ahmed Abd El-Hamid Shedid
Keywords Not Available
Journal Not Available
Publisher Not Available
Volume Not Available
Issue Not Available
Pages Not Available
publication.type International
Paper Link Not Available
Supplementary Materials Not Available
Abstract
Background: Intrauterine growth re-striction is associated with high inci-dence of perinatal mortality and seri-ous long term morbidity. Ferritin is an iron storage protein and failure of se-rum ferritin level to decrease with ad-vancing pregnancy points to impaired iron extraction by the feto-placental unit leading to asymmetric intrauter-ine growth restriction.
Aim of the study: Evaluation of serum ferritin levels at 30-32 weeks gestation as a marker and a predictor of asym-metrical intrauterine growth re-striction.
Patients and Methods: Blood sample was taken from 145 high risk pregnan-cies at 30-32 weeks in the period from July 2014 to March 2015 for estima-tion of serum ferritin level by the en-zyme linked fluorescent assay method. Data of 115 pregnancies were availa-ble at birth and included 85 cases ap-propriate weight for gestational age, 25 cases with asymmetric intrauterine growth restriction and 5 with cases symmetric intrauterine growth re-striction. Serum ferritin levels were analyzed the mean ± SD, the Student t test, the χ2 test and the receiver operat-ing characteristic curve were used .Results were considered signifi-cant at p value